Article Text

Download PDFPDF
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome
  1. B W M van Bon1,
  2. H C Mefford2,
  3. B Menten3,
  4. D A Koolen1,
  5. A J Sharp4,
  6. W M Nillesen1,
  7. J W Innis5,
  8. T J L de Ravel6,
  9. C L Mercer7,
  10. M Fichera8,
  11. H Stewart9,
  12. L E Connell10,
  13. K Õunap11,
  14. K Lachlan7,
  15. B Castle7,
  16. N Van der Aa12,
  17. C van Ravenswaaij1,13,
  18. M A Nobrega14,
  19. C Serra-Juhé15,
  20. I Simonic16,
  21. N de Leeuw1,
  22. R Pfundt1,
  23. E M Bongers1,
  24. C Baker2,
  25. P Finnemore7,
  26. S Huang17,18,19,
  27. V K Maloney18,
  28. J A Crolla17,18,19,
  29. M van Kalmthout1,
  30. M Elia18,
  31. G Vandeweyer12,
  32. J P Fryns6,
  33. S Janssens3,
  34. N Foulds7,
  35. S Reitano8,
  36. K Smith10,
  37. S Parkel11,
  38. B Loeys3,
  39. C G Woods16,
  40. A Oostra3,
  41. F Speleman3,
  42. A C Pereira20,
  43. A Kurg11,
  44. L Willatt16,
  45. S J L Knight21,
  46. J R Vermeesch6,
  47. C Romano8,
  48. J C Barber17,18,19,
  49. G Mortier3,
  50. L A Pérez-Jurado15,22,
  51. F Kooy12,
  52. H G Brunner1,
  53. E E Eichler2,23,
  54. T Kleefstra1,
  55. B B A de Vries1
  1. 1
    Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  2. 2
    Department of Genome Sciences, University of Washington School of Medicine, USA
  3. 3
    Centre for Medical Genetics and Centre for Developmental Disorders, Ghent University Hospital, Ghent, Belgium
  4. 4
    Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
  5. 5
    Department of Human Genetics and Pediatrics, University of Michigan, Ann Arbor, Michigan, USA
  6. 6
    Centre for Human Genetics, University Hospital, Catholic University of Leuven, Leuven, Belgium
  7. 7
    Wessex Clinical Genetics Service, Southampton University Hospitals NHS Trust, Princess Anne Hospital, Southampton, UK
  8. 8
    Laboratory of Genetic Diagnosis, Unit of Pediatrics and Medical Genetics and Unit of Neurology and Clinical Neurophysiology, I.R.C.C.S. Associazione Oasi Maria Santissima, Troina, Italy
  9. 9
    Department of Clinical Genetics, Oxford Radcliffe Hospitals NHS Trust, Churchill Hospital, Oxford, UK
  10. 10
    Oxford Regional Cytogenetics Laboratory, Oxford Radcliffe Hospitals NHS Trust, Churchill Hospital, Oxford, UK
  11. 11
    Institute of Molecular and Cell Biology, University of Tartu/Estonian Biocentre, Tartu, Estonia
  12. 12
    Department of Medical Genetics, University and University Hospital of Antwerp, Antwerp, Belgium
  13. 13
    Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands
  14. 14
    Department of Human Genetics, University of Chicago, Chicago, USA
  15. 15
    Genetics Unit, Universitat Pompeu Fabra, and U735 CIBERER, Barcelona, Spain
  16. 16
    Department of Medical Genetics, Addenbrookes Hospital, Hills Road, Cambridge, UK
  17. 17
    National Genetics Reference Laboratory (Wessex), Salisbury, UK
  18. 18
    Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, UK
  19. 19
    Human Genetics Division, School of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK
  20. 20
    Heart Institute, University of São Paulo Medical School, São Paulo, Brazil
  21. 21
    Oxford Partnership Comprehensive Biomedical Research Centre, The Wellcome Trust Centre for Human Genetics, Churchill Hospital, Oxford, UK
  22. 22
    Program in Molecular Medicine and Genetics, Hospital Universitari Vall d’Hebron, Barcelona, Spain
  23. 23
    Howard Hughes Medical Institute, Seattle, Washington, USA
  1. Dr B B A de Vries, Department of Human Genetics 849, RUNMC, PO Box 9101 6500 HB Nijmegen, The Netherlands; B.devries{at}


Background: Recurrent 15q13.3 microdeletions were recently identified with identical proximal (BP4) and distal (BP5) breakpoints and associated with mild to moderate mental retardation and epilepsy.

Methods: To assess further the clinical implications of this novel 15q13.3 microdeletion syndrome, 18 new probands with a deletion were molecularly and clinically characterised. In addition, we evaluated the characteristics of a family with a more proximal deletion between BP3 and BP4. Finally, four patients with a duplication in the BP3–BP4–BP5 region were included in this study to ascertain the clinical significance of duplications in this region.

Results: The 15q13.3 microdeletion in our series was associated with a highly variable intra- and inter-familial phenotype. At least 11 of the 18 deletions identified were inherited. Moreover, 7 of 10 siblings from four different families also had this deletion: one had a mild developmental delay, four had only learning problems during childhood, but functioned well in daily life as adults, whereas the other two had no learning problems at all. In contrast to previous findings, seizures were not a common feature in our series (only 2 of 17 living probands). Three patients with deletions had cardiac defects and deletion of the KLF13 gene, located in the critical region, may contribute to these abnormalities. The limited data from the single family with the more proximal BP3–BP4 deletion suggest this deletion may have little clinical significance. Patients with duplications of the BP3–BP4–BP5 region did not share a recognisable phenotype, but psychiatric disease was noted in 2 of 4 patients.

Conclusions: Overall, our findings broaden the phenotypic spectrum associated with 15q13.3 deletions and suggest that, in some individuals, deletion of 15q13.3 is not sufficient to cause disease. The existence of microdeletion syndromes, associated with an unpredictable and variable phenotypic outcome, will pose the clinician with diagnostic difficulties and challenge the commonly used paradigm in the diagnostic setting that aberrations inherited from a phenotypically normal parent are usually without clinical consequences.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • ▸ An additional figure is published online only at

  • Funding: This work was supported by grants from the European commission: AnEUploidy project (LSHG-CT-2006-037627) under FP6, and grant agreement 21950 to AJS under FP7 and supplemental grants from the Netherlands Organisation for Health Research and Development (ZonMW 907-00-058, ZonMW 917-86-319 to BBAdV, ZonMW 920-03-338 to DAK), Hersenstichting Nederland (BBAdV). AK was supported by research grant 7617 from the Estonian Science Foundation. SJLK is supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme; the views expressed in this publication are those of the authors and not necessarily those of the Department of Health. EEE is an investigator of the Howard Hughes Medical Institute.

  • Competing interests: None declared.

  • Patient consent: Obtained.